TW201700159A - Method for synthesizing truncated palladium nanocubes - Google Patents

Method for synthesizing truncated palladium nanocubes Download PDF

Info

Publication number
TW201700159A
TW201700159A TW104119826A TW104119826A TW201700159A TW 201700159 A TW201700159 A TW 201700159A TW 104119826 A TW104119826 A TW 104119826A TW 104119826 A TW104119826 A TW 104119826A TW 201700159 A TW201700159 A TW 201700159A
Authority
TW
Taiwan
Prior art keywords
palladium
truncated
ascorbic acid
reaction solution
mixed
Prior art date
Application number
TW104119826A
Other languages
Chinese (zh)
Other versions
TWI539992B (en
Inventor
李建良
黃崑龍
Original Assignee
國立高雄應用科技大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立高雄應用科技大學 filed Critical 國立高雄應用科技大學
Priority to TW104119826A priority Critical patent/TWI539992B/en
Application granted granted Critical
Publication of TWI539992B publication Critical patent/TWI539992B/en
Publication of TW201700159A publication Critical patent/TW201700159A/en

Links

Landscapes

  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
  • Catalysts (AREA)

Abstract

A method for synthesizing truncated palladium nanocubes includes providing a reaction solution containing palladium ion and 0.01-0.125 M cetyltrimethylammonium bromide; and mixing the reaction solution with L-ascorbic acid under a temperature of 70-120 DEG C. Each mole of said palladium ion is mixed with 3.2-19.2 mole of L-ascorbid acid. As such, the truncated palladium nanocubes contain (100) planes (111) planes at the same time.

Description

截角鈀奈米立方體的製備方法 Method for preparing truncated palladium nano cube

本發明係關於一種鈀奈米晶體的製備方法,特別關於一種截角鈀奈米立方體的製備方法。 The invention relates to a preparation method of palladium nanocrystals, in particular to a preparation method of a truncated palladium nanocrystal cube.

鈀(Palladium)的奈米晶體具有良好的觸媒反應活性,可以用於作為多種反應的催化劑,例如用於氧還原反應(oxygen reduction reaction)或甲酸氧化反應(formic acid oxidation)等。鈀奈米晶體可以具有不同的晶型及大小,例如可以形成具有(100)平面的鈀奈米立方體,或具有(111)平面的鈀奈米八面體,且可以具有不同的尺寸大小。 The crystal of palladium has good catalytic activity and can be used as a catalyst for various reactions, for example, for oxygen reduction reaction or formic acid oxidation. The palladium nanocrystals may have different crystal forms and sizes, for example, a palladium nanocube having a (100) plane, or a palladium nanooctahedron having a (111) plane, and may have different sizes.

目前的研究指出,鈀奈米晶體的觸媒反應活性與其晶體型態有密切的相關性,具有不同平面的鈀奈米晶體適用於不同的催化反應。例如,於過氯酸水溶液中進行氧還原反應時,鈀(100)平面之催化效率遠大於鈀(111)平面。若於一鈀奈米晶體中同時存在兩種以上之平面,則可以同時具有兩種不同之觸媒反應活性,而能應用多種不同催化反應中。此外,一般而言,尺寸較小之鈀奈米晶體通常具有較佳之催化效率。因此,藉由調控鈀奈米晶體的型態,可以改變其觸媒反應活性,提升其作為觸媒的應用性。 The current research indicates that the catalytic activity of palladium nanocrystals is closely related to its crystal form, and palladium nanocrystals with different planes are suitable for different catalytic reactions. For example, when an oxygen reduction reaction is carried out in an aqueous perchloric acid solution, the catalytic efficiency of the palladium (100) plane is much larger than that of the palladium (111) plane. If more than two planes exist in a palladium nanocrystal, it can simultaneously have two different catalyst reactivity, and can be applied in a variety of different catalytic reactions. In addition, in general, smaller diameter palladium nanocrystals generally have better catalytic efficiency. Therefore, by regulating the type of palladium nanocrystals, the catalytic activity of the catalyst can be changed, and its applicability as a catalyst can be improved.

習知鈀奈米晶體的製備方法,係於水溶液中混合聚乙烯吡咯酮(poly(vinylpyrrolidone))、抗壞血酸(L-ascorbic acid)、氯化鉀、溴化鉀及氯鈀酸鈉(Na2PdCl4),並於80℃下加熱攪拌3小時,以生成具有(100) 平面之鈀奈米立方體。惟,上述方法製得之鈀奈米晶體,僅具有單一種類之平面,其應用範圍較窄,仍有改善之空間。 The preparation method of the conventional palladium nanocrystal is mixed with poly(vinylpyrrolidone), ascorbic acid (L-ascorbic acid), potassium chloride, potassium bromide and sodium chloropalladate (Na 2 PdCl) in an aqueous solution. 4 ), and heating and stirring at 80 ° C for 3 hours to form a palladium nano-cube having a (100) plane. However, the palladium nanocrystals obtained by the above method have only a single type of plane, and the application range is narrow, and there is still room for improvement.

本發明之目的係提供一種截角鈀奈米立方體的製備方法,所製得之截角鈀奈米立方體同時具有兩種平面者。 SUMMARY OF THE INVENTION The object of the present invention is to provide a method for preparing a truncated palladium nanocube which has two planes at the same time.

本發明提供一種截角鈀奈米立方體的製備方法,係包含:提供一反應溶液,該反應溶液係包含鈀離子及0.01~0.025M之十六烷基三甲基溴化銨;及於70~120℃之溫度下,將該反應溶液與抗壞血酸混合;其中,每莫耳鈀離子係混合3.2~19.2莫耳之抗壞血酸。 The present invention provides a method for preparing a truncated palladium nanocube, comprising: providing a reaction solution comprising palladium ions and 0.01 to 0.025 M of cetyltrimethylammonium bromide; and 70~ The reaction solution was mixed with ascorbic acid at a temperature of 120 ° C; wherein, per mole of palladium ion was mixed with 3.2 to 19.2 moles of ascorbic acid.

本發明之截角鈀奈米立方體的製備方法,其中,係於90~100℃之溫度下,將該反應溶液與抗壞血酸混合。 The method for preparing a truncated palladium nanocube of the present invention, wherein the reaction solution is mixed with ascorbic acid at a temperature of 90 to 100 °C.

本發明之截角鈀奈米立方體的製備方法,其中,係於95℃之溫度下,將該反應溶液與抗壞血酸混合。 The method for producing a truncated palladium nanocube of the present invention, wherein the reaction solution is mixed with ascorbic acid at a temperature of 95 °C.

本發明之截角鈀奈米立方體的製備方法,其中,另包含於將該反應溶液與抗壞血酸混合後,靜置30分鐘以形成截角鈀奈米立方體。 The method for producing a truncated palladium nanocube of the present invention, further comprising mixing the reaction solution with ascorbic acid, and then allowing to stand for 30 minutes to form a truncated palladium nanocrystal cube.

本發明之截角鈀奈米立方體的製備方法,其中,該鈀離子係來自硝酸鈀(Pd(NO3)2)、醋酸鈀(Pd(OAc)2)、氯化鈀(PdCl2)、氯鈀酸鈉(Na2PdCl4)、六氯鈀酸鉀(K2PdCl6)或四氯鈀酸鉀(K2PdCl4)。 The method for preparing a truncated palladium nanocube of the present invention, wherein the palladium ion is derived from palladium nitrate (Pd(NO 3 ) 2 ), palladium acetate (Pd(OAc) 2 ), palladium chloride (PdCl 2 ), chlorine Sodium palladium (Na 2 PdCl 4 ), potassium hexachloropalladate (K 2 PdCl 6 ) or potassium tetrachloropalladate (K 2 PdCl 4 ).

本發明之截角鈀奈米立方體的製備方法,其中,提供該反應溶液係包含混合濃度為0.01M之一鈀離子水溶液500μl及濃度為0.0125M之十六烷基三甲基溴化銨水溶液10ml。 The method for preparing a truncated palladium nanocube of the present invention, wherein the reaction solution comprises a solution of 500 μl of a palladium ion aqueous solution having a mixed concentration of 0.01 M and a solution of a cetyltrimethylammonium bromide aqueous solution having a concentration of 0.0125 M, 10 ml. .

本發明之截角鈀奈米立方體的製備方法,其中,將該反應溶液與抗壞血酸混合係包含將該反應溶液與濃度為0.01M之抗壞血酸水溶液混合。 The method for producing a truncated palladium nanocube according to the present invention, wherein the reaction solution is mixed with ascorbic acid, and the reaction solution is mixed with an aqueous solution of ascorbic acid having a concentration of 0.01 M.

本發明之截角鈀奈米立方體的製備方法,其中,該鈀離子水 溶液係為氯鈀酸(H2PdCl4)水溶液。 The method for producing a truncated palladium nanocrystal of the present invention, wherein the aqueous palladium ion solution is an aqueous solution of chloropalladic acid (H 2 PdCl 4 ).

本發明之截角鈀奈米立方體的製備方法,藉由將包含鈀離子及C16TAB之該反應溶液與抗壞血酸混合,而能夠製備該截角鈀奈米立方體。該截角鈀奈米立方體同時具有(100)及(111)平面,而能夠提供雙重觸媒反應活性,進而達到提升該截角鈀奈米立方體應用性之功效。 In the method for preparing a truncated palladium nanocube of the present invention, the truncated palladium nanocrystal cube can be prepared by mixing the reaction solution containing palladium ions and C 16 TAB with ascorbic acid. The truncated palladium nanocube has both (100) and (111) planes, and can provide dual catalyst reactivity, thereby improving the applicability of the truncated palladium nanocube.

再者,由於本發明之截角鈀奈米立方體的製備方法,藉由調控抗壞血酸與鈀離子之比例,可以生成粒徑約為10~15nm之截角鈀奈米立方體,縮小該截角鈀奈米立方體之粒徑,進而於使用該截角鈀奈米立方體於催化反應時,達成提升催化效率之功效。 Furthermore, due to the method for preparing the truncated palladium nanocube of the present invention, by adjusting the ratio of ascorbic acid to palladium ions, a truncated palladium nanocrystal having a particle diameter of about 10 to 15 nm can be formed, and the truncated palladium can be reduced. The particle size of the rice cube, in turn, achieves the effect of improving the catalytic efficiency when the chopped palladium nano-cube is used for the catalytic reaction.

此外,本發明之截角鈀奈米立方體的製備方法,所使用之藥品相較於習知之鈀奈米晶體的製備方法更少,且所需加熱時間亦較短,故而可以達成簡化製備流程、提升製程效率及減少能源耗費等功效。 In addition, the preparation method of the truncated palladium nanocube of the present invention uses less preparation method than the conventional palladium nanocrystal, and the required heating time is shorter, so that the simplified preparation process can be achieved. Improve process efficiency and reduce energy consumption.

1‧‧‧(100)平面 1‧‧‧(100) plane

2‧‧‧(111)平面 2‧‧‧(111) plane

第1圖係截角鈀奈米立方體之結構示意圖。 Figure 1 is a schematic view showing the structure of a truncated palladium nano-cube.

第2a圖係第A1組之穿透式電子顯微影像。 Figure 2a is a transmission electron micrograph of Group A1.

第2b圖係第A2組之穿透式電子顯微影像。 Figure 2b is a transmission electron micrograph of Group A2.

第2c圖係第A3組之穿透式電子顯微影像。 Figure 2c is a transmission electron micrograph of Group A3.

第2d圖係第A4組之穿透式電子顯微影像。 Figure 2d is a transmission electron micrograph of Group A4.

第3圖係第A1~A4組之鈀奈米晶體形貌分布柱狀圖。 Figure 3 is a histogram of the crystal morphology distribution of palladium nanoparticles in Groups A1 to A4.

第4a圖係第B1組之穿透式電子顯微影像。 Figure 4a is a transmission electron micrograph of Group B1.

第4b圖係第B2組之穿透式電子顯微影像。 Figure 4b is a transmission electron micrograph of Group B2.

第4c圖係第B3組之穿透式電子顯微影像。 Figure 4c is a transmission electron micrograph of Group B3.

第4d圖係第B4組之穿透式電子顯微影像。 Figure 4d is a transmission electron micrograph of Group B4.

第5圖係第B1~B4組之鈀奈米晶體形貌分布柱狀圖。 Figure 5 is a histogram of the crystal morphology distribution of palladium nanoparticles in Groups B1 to B4.

第6a圖係第C1組之穿透式電子顯微影像。 Figure 6a is a transmission electron micrograph of Group C1.

第6b圖係第C2組之穿透式電子顯微影像。 Figure 6b is a transmission electron micrograph of Group C2.

第6c圖係第C3組之穿透式電子顯微影像。 Figure 6c is a transmission electron micrograph of Group C3.

第6d圖係第C4組之穿透式電子顯微影像。 Figure 6d is a transmission electron micrograph of Group C4.

第7圖係第C1~C4組之鈀奈米晶體形貌分布柱狀圖。 Figure 7 is a histogram of the crystal morphology distribution of palladium nanoparticles in Groups C1~C4.

第8圖係第C3組之高解析穿透式電子顯微影像。 Figure 8 is a high resolution transmission electron micrograph of Group C3.

第9圖係第C3組之X光繞射光譜。 Figure 9 is the X-ray diffraction spectrum of Group C3.

第10圖係第C3組之電子繞射圖譜。 Figure 10 is an electron diffraction pattern of Group C3.

為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式,作詳細說明如下: The above and other objects, features and advantages of the present invention will become more <RTIgt;

本發明係關於一種截角鈀奈米立方體的製備方法,係將包含鈀離子、十六烷基三甲基溴化銨之一反應溶液與抗壞血酸混合,以製得一截角鈀奈米立方體。 The invention relates to a method for preparing a truncated palladium nanocube, which comprises mixing a reaction solution containing palladium ions and cetyltrimethylammonium bromide with ascorbic acid to obtain a truncated palladium nanocrystal cube.

本發明之截角鈀奈米立方體(truncated palladium nanocubes)係於具有(100)平面的立方體中,分別於其八個角處形成(111)平面。如第1圖所示,該截角鈀奈米立方體具有八角形之(100)面1及三角形之(111)面2,且上述八角形面共有6個,而三角形面共有8個。 The truncated palladium nanocubes of the present invention are in a cube having a (100) plane, forming a (111) plane at eight corners thereof, respectively. As shown in Fig. 1, the truncated palladium nano-cube has an octagonal (100) plane 1 and a triangular (111) plane 2, and the octagonal plane has 6 in total, and the triangular plane has 8 in total.

該鈀離子係可以來自任何能夠解離生成鈀離子之鹽類,例如硝酸鈀(Pd(NO3)2)、醋酸鈀(Pd(OAc)2)、氯化鈀(PdCl2)、氯鈀酸鈉(Na2PdCl4)、六氯鈀酸鉀(K2PdCl6)或四氯鈀酸鉀(K2PdCl4)等,本發明不加以限制。 The palladium ion may be derived from any salt capable of dissociating to form palladium ions, such as palladium nitrate (Pd(NO 3 ) 2 ), palladium acetate (Pd(OAc) 2 ), palladium chloride (PdCl 2 ), sodium chloropalladate. (Na 2 PdCl 4 ), potassium hexachloropalladate (K 2 PdCl 6 ) or potassium tetrachloropalladate (K 2 PdCl 4 ), etc., are not limited in the present invention.

十六烷基三甲基溴化銨(cetyltrimethylammonium bromide,簡稱C16TAB)係為一種界面活性劑,其可以作為奈米粒子包覆劑(capping agent)及結構導向劑(structure-directing agent),以輔助截角鈀金屬立方 體之生成。 Cetyltrimethylammonium bromide (C 16 TAB) is a surfactant which can be used as a nanoparticle capping agent and a structure-directing agent. The formation of an auxiliary truncated palladium metal cube.

更詳言之,係可以將上述包含鈀離子之鹽類及C16TAB共同溶解於水中以形成該反應溶液。或者,另可以先製備一鈀離子水溶液及一C16TAB水溶液,續混合該鈀離子水溶液及該C16TAB水溶液以形成該反應溶液。例如於本實施例中,係將氯化鈀溶解於鹽酸水溶液中以形成一氯鈀酸(H2PdCl4)水溶液,續與該C16TAB水溶液混合。 More specifically, the above-mentioned salt containing palladium ions and C 16 TAB may be dissolved together in water to form the reaction solution. Or, alternatively, it may be first prepared an aqueous solution of a palladium ion and an aqueous solution of a C 16 TAB, continued mixing the palladium ion solution and the aqueous solution 16 TAB C to form the reaction solution. For example, in the present embodiment, palladium chloride is dissolved in an aqueous hydrochloric acid solution to form an aqueous solution of monochloropalladium acid (H 2 PdCl 4 ), which is continuously mixed with the aqueous solution of C 16 TAB.

抗壞血酸係為一種還原劑,其可以還原鈀離子以生成鈀金屬。透過調控抗壞血酸相對於鈀離子的添加量,可以生成不同型態之鈀奈米晶體。於本實施例中,係能夠先將抗壞血酸溶解於水中以形成一抗壞血酸水溶液,續用以進行後續反應。 Ascorbic acid is a reducing agent that can reduce palladium ions to form palladium metal. By adjusting the amount of ascorbic acid added relative to the palladium ion, different types of palladium nanocrystals can be formed. In this embodiment, ascorbic acid can be first dissolved in water to form an aqueous solution of ascorbic acid, which is continued for subsequent reaction.

本發明係於70~120℃之溫度下,混合該反應溶液及抗壞血酸,該反應溶液係包含0.01~0.025M之C16TAB,且每莫耳鈀離子係混合3.2~19.2莫耳之抗壞血酸。藉由上述鈀離子與抗壞血酸之比例,可以使抗壞血酸還原鈀離子,以生成該截角鈀奈米立方體。此外,藉由適當濃度之C16TAB及特定反應溫度,而能夠生成該截角鈀奈米立方體,並可以避免柱狀、四面體之鈀奈米晶體的生成。若控制反應溫度於90~100℃,可以更進一步提高該截角鈀奈米立方體的產率。 In the present invention, the reaction solution and ascorbic acid are mixed at a temperature of 70 to 120 ° C. The reaction solution contains 0.01 to 0.025 M of C 16 TAB, and 3.2 to 19.2 moles of ascorbic acid is mixed per mole of palladium ion. By the ratio of the above palladium ion to ascorbic acid, ascorbic acid can be reduced to palladium ions to form the truncated palladium nanocrystal cube. In addition, the chopped palladium nanocrystal cube can be formed by a suitable concentration of C 16 TAB and a specific reaction temperature, and the formation of columnar or tetrahedral palladium nanocrystals can be avoided. If the reaction temperature is controlled at 90 to 100 ° C, the yield of the truncated palladium nanocube can be further improved.

該反應溶液係能夠透過將0.01M之鈀離子水溶液0.5ml混合0.0125M之該C16TAB水溶液10ml以製得,藉由上述配比,可以提高該截角鈀奈米立方體的產率,並使該截角鈀奈米立方體的尺寸較均一。例如於本實施例中,係取0.01M之該氯鈀酸水溶液0.5ml混合0.0125M之該C16TAB水溶液10ml,續於95℃之溫度下,加入0.1M之該抗壞血酸水溶液0.16~0.96ml,並以電磁攪拌混合1分鐘,而後靜置30分鐘以形成粒徑約為10~15nm之截角鈀奈米立方體。 The reaction solution can be prepared by mixing 0.01 ml of a 0.01 M aqueous solution of palladium ion in 0.0125 M of 10 ml of the C 16 TAB aqueous solution, and by using the above ratio, the yield of the truncated palladium nanocube can be improved and The truncated palladium nano-cube is relatively uniform in size. For example, in the present embodiment, 0.01 ml of the aqueous solution of 0.01 mg of the aqueous solution of palladium palladium is mixed with 0.0125 M of 10 ml of the C 16 TAB aqueous solution, and 0.1 M to 0.16 ml of the ascorbic acid aqueous solution is added at a temperature of 95 ° C. The mixture was mixed by electromagnetic stirring for 1 minute, and then allowed to stand for 30 minutes to form a truncated palladium nanocrystal having a particle diameter of about 10 to 15 nm.

本發明藉由提供包含鈀離子及0.01~0.025M之C16TAB的 該反應溶液,並於70~120℃之溫度下,混合該反應溶液及抗壞血酸,使每莫耳鈀離子混合3.2~19.2莫耳之抗壞血酸,而可以生成該截角鈀奈米立方體。上述截角鈀奈米立方體同時具有(100)平面及(111)平面,具有雙重觸媒反應活性,而能夠更廣泛地應用於催化反應中。 The present invention provides a reaction solution containing palladium ions and 0.016 to 0.025M of C 16 TAB, and mixes the reaction solution and ascorbic acid at a temperature of 70 to 120 ° C to mix 3.2 to 19.2 moles per mole of palladium ions. The ascorbic acid of the ear can be generated to form the truncated palladium nanocrystal cube. The above-mentioned truncated palladium nano-cube has both (100) plane and (111) plane, has dual catalyst reactivity, and can be more widely used in catalytic reactions.

為證實本發明之截角鈀奈米立方體的製備方法,藉由特定反應溫度及鈀離子與抗壞血酸之比例,確實可以生成該截角鈀奈米立方體,遂進行下述實驗。 In order to confirm the preparation method of the truncated palladium nanocube of the present invention, the truncated palladium nanocube cube can be surely formed by a specific reaction temperature and the ratio of palladium ion to ascorbic acid, and the following experiment is carried out.

(A)反應溫度之影響 (A) Effect of reaction temperature

取0.01M之該氯鈀酸水溶液0.5ml混合0.0125M之該C16TAB水溶液10ml,作為第A1~A4組,續於不同之反應溫度下,加入0.1M之該抗壞血酸水溶液0.08ml,攪拌1分鐘並靜置30分鐘,第A1~A4組之反應溫度係如下第1表所示。 Take 0.01 ml of this aqueous solution of chloropalladium acid in 0.5 ml and mix 0.015 M of 10 ml of the C 16 TAB aqueous solution as the A1~A4 group, and add 0.1 M of the ascorbic acid aqueous solution at a different reaction temperature, and stir for 1 minute. After standing for 30 minutes, the reaction temperatures of the groups A1 to A4 are shown in Table 1 below.

以穿透式電子顯微鏡觀察第A1~A4組所形成之鈀奈米晶體的結構,係如第2a~2d圖所示。另分析各組鈀奈米晶體之形貌,繪示如第3圖之柱狀圖,紀錄其中立方體之粒徑如上第1表所示。由上述結果可知,於70~120℃之溫度下,可以使所形成之鈀奈米晶體以立方體為主,特別係第A2組,於95℃之溫度下,鈀奈米立方體的產率約為95%。 The structure of the palladium nanocrystals formed in Groups A1 to A4 was observed by a transmission electron microscope as shown in Figures 2a to 2d. The morphology of each group of palladium nanocrystals was also analyzed, and a histogram as shown in Fig. 3 was drawn, and the particle size of the cube was recorded as shown in the first table. From the above results, it can be seen that at the temperature of 70-120 ° C, the formed palladium nanocrystals can be mainly cubic, especially in the group A2. At a temperature of 95 ° C, the yield of the palladium nano-cube is about 95%.

(B)C16TAB濃度之影響 (B) Effect of C 16 TAB concentration

取0.01M之該氯鈀酸水溶液0.5ml混合不同濃度之該 C16TAB水溶液10ml,作為第B1~B4組,續於95℃之溫度下,加入0.1M之該抗壞血酸水溶液0.08ml,攪拌1分鐘並靜置30分鐘,第B1~B4組之該C16TAB水溶液的濃度係如下第2表所示。 Take 0.01 ml of this aqueous solution of chloropalladium acid in 0.5 ml and mix 10 ml of the C 16 TAB aqueous solution at different concentrations as the B1~B4 group, and then add 0.1 M of the ascorbic acid aqueous solution at a temperature of 95 ° C, and stir for 1 minute. After standing for 30 minutes, the concentration of the C 16 TAB aqueous solution in Groups B1 to B4 is shown in Table 2 below.

以穿透式電子顯微鏡觀察第B1~B4組所形成之鈀奈米晶體的結構,係如第4a~4d圖所示。另分析各組鈀奈米晶體之形貌,繪示如第5圖之柱狀圖,紀錄其中立方體之粒徑如上第2表所示。由上述結果可知,第B1、B2組選用0.0125~0.025M之該C16TAB水溶液(即,使該反應溶液中含有0.01~0.025M之C16TAB),可以使所形成之鈀奈米晶體以立方體為主。特別係第B2組,選用0.0125M之該C16TAB水溶液,鈀奈米立方體的產率約為95%。 The structure of the palladium nanocrystals formed in Groups B1 to B4 was observed by a transmission electron microscope as shown in Figures 4a to 4d. The morphology of each group of palladium nanocrystals was also analyzed, and the histogram as shown in Fig. 5 was plotted, and the particle size of the cube was recorded as shown in the second table. From these results, the first B1, B2 group selected 0.0125 ~ 0.025M aqueous solution of the C 16 TAB (i.e., the reaction solution contains 0.01 ~ 0.025M of C 16 TAB), palladium nanocrystals can be formed in the The cube is dominant. In particular, in Group B2, 0.0125 M of the C 16 TAB aqueous solution was used, and the yield of the palladium nanocube was about 95%.

(C)抗壞血酸添加量之影響 (C) Effect of the amount of ascorbic acid added

取0.01M之該氯鈀酸水溶液0.5ml混合0.0125M之該C16TAB水溶液10ml,作為第B1~B4組,續於95℃之溫度下,分別加入不同體積之0.1M抗壞血酸水溶液,攪拌1分鐘並靜置30分鐘,第C1~C4組之抗壞血酸水溶液添加體積係如下第3表所示。 Take 0.01M of 0.5 ml of the aqueous solution of chloropalladium acid and mix 0.015 M of 10 ml of the C 16 TAB aqueous solution as the B1~B4 group, and then add different volumes of 0.1 M aqueous ascorbic acid solution at a temperature of 95 ° C, and stir for 1 minute. After standing for 30 minutes, the volume of the ascorbic acid aqueous solution added to the C1 to C4 groups is shown in Table 3 below.

以穿透式電子顯微鏡觀察第C1~C4組所形成之鈀奈米晶體的結構,係如第6a~6d圖所示。另分析各組鈀奈米晶體之形貌,繪示如第7圖之柱狀圖,紀錄其中立方體之粒徑如上第3表所示。由上述結果可知,添加0.16~0.96ml之該抗壞血酸水溶液(即,每莫耳之鈀離子混合3.2~19.2莫耳之抗壞血酸),可以使所形成之鈀奈米晶體以立方體為主,且其粒徑可以達到10~15nm。 The structure of the palladium nanocrystals formed in the C1 to C4 groups was observed by a transmission electron microscope as shown in Figs. 6a to 6d. The morphology of each group of palladium nanocrystals was also analyzed, and a histogram as shown in Fig. 7 was drawn, and the particle size of the cube was recorded as shown in the third table. From the above results, it is known that 0.16 to 0.96 ml of the ascorbic acid aqueous solution (that is, 3.2 to 19.2 moles of ascorbic acid per mole of palladium ion) is added, so that the formed palladium nanocrystals are mainly cubic, and the particles thereof The diameter can reach 10~15nm.

進一步分析上述第C2~C4組,可以得知所形成之鈀奈米晶體皆以截角鈀奈米立方體為主。以第C3組為例,其高解析穿透式電子顯微鏡圖係如第8圖所示,而並進行X光繞射光譜分析(XRD)如第9圖所示,及電子繞射圖譜如第10圖所示。上述資料可以證實,藉由本發明截角鈀奈米立方體的製備方法,確實能夠生成同時具有(100)平面及(111)平面之截角鈀奈米立方體。 Further analysis of the above C2~C4 group shows that the formed palladium nanocrystals are mainly truncated palladium nanocrystals. Taking the C3 group as an example, the high-resolution transmission electron microscope image is shown in Fig. 8, and the X-ray diffraction spectrum analysis (XRD) is shown in Fig. 9, and the electron diffraction pattern is as shown in the figure. Figure 10 shows. The above data can confirm that, by the preparation method of the truncated palladium nano-cube of the present invention, it is indeed possible to generate a truncated palladium nano-cube having both a (100) plane and a (111) plane.

綜合上述,本發明之截角鈀奈米立方體的製備方法,藉由將包含鈀離子及C16TAB之該反應溶液與抗壞血酸混合,而能夠製備該截角鈀奈米立方體。該截角鈀奈米立方體同時具有(100)及(111)平面,而能夠提供雙重觸媒反應活性,進而達到提升該截角鈀奈米立方體應用性之功效。 In summary, in the above method for producing a truncated palladium nanocube of the present invention, the truncated palladium nanocrystal cube can be prepared by mixing the reaction solution containing palladium ions and C 16 TAB with ascorbic acid. The truncated palladium nanocube has both (100) and (111) planes, and can provide dual catalyst reactivity, thereby improving the applicability of the truncated palladium nanocube.

再者,由於本發明之截角鈀奈米立方體的製備方法,藉由調控抗壞血酸與鈀離子之比例,可以生成粒徑約為10~15nm之截角鈀奈米立方體,縮小該截角鈀奈米立方體之粒徑,進而於使用該截角鈀奈米立方體於催化反應時,達成提升催化效率之功效。 Furthermore, due to the method for preparing the truncated palladium nanocube of the present invention, by adjusting the ratio of ascorbic acid to palladium ions, a truncated palladium nanocrystal having a particle diameter of about 10 to 15 nm can be formed, and the truncated palladium can be reduced. The particle size of the rice cube, in turn, achieves the effect of improving the catalytic efficiency when the chopped palladium nano-cube is used for the catalytic reaction.

此外,本發明之截角鈀奈米立方體的製備方法,所使用之藥品相較於習知之鈀奈米晶體的製備方法更少,且所需加熱時間亦較短,故而可以達成簡化製備流程、提升製程效率及減少能源耗費等功效。 In addition, the preparation method of the truncated palladium nanocube of the present invention uses less preparation method than the conventional palladium nanocrystal, and the required heating time is shorter, so that the simplified preparation process can be achieved. Improve process efficiency and reduce energy consumption.

雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the invention has been described in connection with the preferred embodiments described above, it is not intended to limit the scope of the invention. The technical scope of the invention is protected, and therefore the scope of the invention is defined by the scope of the appended claims.

Claims (8)

一種截角鈀奈米立方體的製備方法,係包含:提供一反應溶液,該反應溶液係包含鈀離子及0.01~0.025M之十六烷基三甲基溴化銨;及於70~120℃之溫度下,將該反應溶液與抗壞血酸混合;其中,每莫耳鈀離子係混合3.2~19.2莫耳之抗壞血酸。 A method for preparing a truncated palladium nanocube comprises: providing a reaction solution comprising palladium ions and 0.01 to 0.025 M of cetyltrimethylammonium bromide; and 70 to 120 ° C The reaction solution is mixed with ascorbic acid at a temperature; wherein, each mole of palladium ion is mixed with 3.2 to 19.2 moles of ascorbic acid. 如申請專利範圍第1項所述之截角鈀奈米立方體的製備方法,其中,係於90~100℃之溫度下,將該反應溶液與抗壞血酸混合。 The method for preparing a truncated palladium nanocube according to claim 1, wherein the reaction solution is mixed with ascorbic acid at a temperature of 90 to 100 °C. 如申請專利範圍第2項所述之截角鈀奈米立方體的製備方法,其中,係於95℃之溫度下,將該反應溶液與抗壞血酸混合。 The method for producing a truncated palladium nanocube according to claim 2, wherein the reaction solution is mixed with ascorbic acid at a temperature of 95 °C. 如申請專利範圍第1項所述之截角鈀奈米立方體的製備方法,其中,另包含於將該反應溶液與抗壞血酸混合後,靜置30分鐘以形成截角鈀奈米立方體。 The method for preparing a truncated palladium nanocube according to claim 1, wherein the reaction solution is mixed with ascorbic acid and allowed to stand for 30 minutes to form a truncated palladium nanocube. 如申請專利範圍第1項所述之截角鈀奈米立方體的製備方法,其中,該鈀離子係來自硝酸鈀(Pd(NO3)2)、醋酸鈀(Pd(OAc)2)、氯化鈀(PdCl2)、氯鈀酸鈉(Na2PdCl4)、六氯鈀酸鉀(K2PdCl6)或四氯鈀酸鉀(K2PdCl4)。 The method for preparing a truncated palladium nanocube according to claim 1, wherein the palladium ion is derived from palladium nitrate (Pd(NO 3 ) 2 ), palladium acetate (Pd(OAc) 2 ), and chlorinated. Palladium (PdCl 2 ), sodium chloropalladate (Na 2 PdCl 4 ), potassium hexachloropalladate (K 2 PdCl 6 ) or potassium tetrachloropalladate (K 2 PdCl 4 ). 如申請專利範圍第1~5項任一項所述之截角鈀奈米立方體的製備方法,其中,提供該反應溶液係包含混合濃度為0.01M之一鈀離子水溶液500μl及濃度為0.0125M之十六烷基三甲基溴化銨水溶液10ml。 The method for preparing a truncated palladium nanocube according to any one of claims 1 to 5, wherein the reaction solution comprises 500 μl of a palladium ion aqueous solution having a mixed concentration of 0.01 M and a concentration of 0.0125 M. 10 ml of an aqueous solution of cetyltrimethylammonium bromide. 如申請專利範圍第6項所述之截角鈀奈米立方體的製備方法,其中,將該反應溶液與抗壞血酸混合係包含將該反應溶液與濃度為0.1M之抗壞血酸水溶液混合。 The method for producing a truncated palladium nanocube according to claim 6, wherein the reaction solution is mixed with ascorbic acid, and the reaction solution is mixed with an aqueous solution of ascorbic acid having a concentration of 0.1 M. 如申請專利範圍第6項所述之截角鈀奈米立方體的製備方法,其 中,該鈀離子水溶液係為氯鈀酸(H2PdCl4)水溶液。 The method for producing a truncated palladium nanocube according to claim 6, wherein the aqueous palladium ion solution is an aqueous solution of chloropalladium acid (H 2 PdCl 4 ).
TW104119826A 2015-06-18 2015-06-18 Method for synthesizing truncated palladium nanocubes TWI539992B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW104119826A TWI539992B (en) 2015-06-18 2015-06-18 Method for synthesizing truncated palladium nanocubes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW104119826A TWI539992B (en) 2015-06-18 2015-06-18 Method for synthesizing truncated palladium nanocubes

Publications (2)

Publication Number Publication Date
TWI539992B TWI539992B (en) 2016-07-01
TW201700159A true TW201700159A (en) 2017-01-01

Family

ID=56996989

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104119826A TWI539992B (en) 2015-06-18 2015-06-18 Method for synthesizing truncated palladium nanocubes

Country Status (1)

Country Link
TW (1) TWI539992B (en)

Also Published As

Publication number Publication date
TWI539992B (en) 2016-07-01

Similar Documents

Publication Publication Date Title
EP2103364B1 (en) Process for manufacture of nanometric, monodisperse and stable metallic silver and product obtained therefrom
Kim et al. Shape-dependent catalytic activity of palladium nanoparticles for the direct synthesis of hydrogen peroxide from hydrogen and oxygen
He et al. Controlled synthesis of CeO2 nanoparticles from the coupling route of homogenous precipitation with microemulsion
Parnklang et al. Shape transformation of silver nanospheres to silver nanoplates induced by redox reaction of hydrogen peroxide
CN106563814B (en) A kind of controllable method for preparing of light inducible to silver nanoparticle triangular plate
US20120046482A1 (en) Method for synthesizing gold nanoparticles
CA2829095C (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
Chang et al. High-yield water-based synthesis of truncated silver nanocubes
CN103708560B (en) Preparation method of nano tungsten trioxide powder
CN102602883A (en) Preparation method of silica-coated iron oxide nano-core-shell structural material
Zhu et al. Room-temperature synthesis of cuprous oxide and its heterogeneous nanostructures for photocatalytic applications
CN104528787B (en) A kind of method preparing fine grain size alumina powder
CN108452816B (en) Small-particle-size metal phosphide nanoparticle/reduced graphene composite material and preparation method thereof
Gu et al. Effect of aqueous ammonia addition on the morphology and size of silver particles reduced by ascorbic acid
CN113814408A (en) Preparation of CuPd alloy nanocrystalline and component regulation and control method thereof
TWI539992B (en) Method for synthesizing truncated palladium nanocubes
CN113118432B (en) Noble metal nano particle and preparation method and application thereof
Hong et al. Kinetically Controlled Growth of Gold Nanoplates and Nanorods via a One-Step Seed-Mediated Method.
JP2006265714A (en) Method for producing metal acicular body-containing metal particulate
JP2011042541A (en) Nickel oxide fine powder and method for producing the same
JP2006265713A (en) Method for producing metal acicular body-containing metal particulate
JP5485122B2 (en) Sulfur-containing nickel particles and method for producing the same
JP2009035773A (en) Method for producing tin nanoparticle
Martinez et al. On the use of Tequila for the biosynthesis of SiO2 nanoparticles
Yu et al. Solution synthesis protocols for shaping mixed valent oxide crystalline particles as robust catalytic materials

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees